Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Practical Laboratory Medicine
|
February 29, 2024
Temperature stability of urinary F<sub>2</sub>-isoprostane and 8-hydroxy-2<i>'</i>-deoxyguanosine
Katarzyna Kordas, Diala Ghazal, Elena I Queirolo, et al.
Neurotoxicology
|
April 6, 2025
Lead exposure, peripheral neurotransmitter levels and cognitive control: A neurobehavioral study in children from Montevideo, Uruguay
Gabriel Barg, Juan Andrés Menéndez, Juan Andrés Friedl, et al.
European Journal of Neurology
|
May 8, 2023
Antioxidant defense enzymes in multiple sclerosis: A 5-year follow-up study
Carson Essenburg, Richard W Browne, Diala Ghazal, et al.
Multiple Sclerosis and Related Disorders
|
December 1, 2023
Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosis
Nasim Nehzat, Richard W Browne, Diala Ghazal, et al.
Antioxidants (Basel, Switzerland)
|
January 28, 2026
Oxylipin Biomarkers of Auto-Oxidation Are Associated with Antioxidant Micronutrients and Multiple Sclerosis Disability
Taylor R Wicks, Anna Wolska, Diala Ghazal, et al.
Journal of Environmental Exposure Assessment
|
April 9, 2026
Exposure to a mixture of four metals and associations with urinary oxidative stress biomarkers in Uruguayan adolescents
Katarzyna Kordas, David L Glotzer, Gauri Desai, et al.
Oncotarget
|
October 20, 2022
Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models
Diala Ghazal, Fatma Zalzala, John C Fisk, et al.
Annals of Clinical and Translational Neurology
|
November 14, 2025
Frailty Exacerbates Disability in Progressive Multiple Sclerosis
Taylor R Wicks, Anna Wolska, Diala Ghazal, et al.
Translational Oncology
|
February 26, 2018
Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging
Loukia G Karacosta, John C Fisk, Joseph Jessee, et al.
Neoplasia (New York, N.Y.)
|
December 27, 2017
Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733]
Swetha Tati, John C Fisk, Julia Abdullah, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Practical Laboratory Medicine
|
February 29, 2024
Temperature stability of urinary F<sub>2</sub>-isoprostane and 8-hydroxy-2<i>'</i>-deoxyguanosine
Katarzyna Kordas, Diala Ghazal, Elena I Queirolo, et al.
Neurotoxicology
|
April 6, 2025
Lead exposure, peripheral neurotransmitter levels and cognitive control: A neurobehavioral study in children from Montevideo, Uruguay
Gabriel Barg, Juan Andrés Menéndez, Juan Andrés Friedl, et al.
European Journal of Neurology
|
May 8, 2023
Antioxidant defense enzymes in multiple sclerosis: A 5-year follow-up study
Carson Essenburg, Richard W Browne, Diala Ghazal, et al.
Multiple Sclerosis and Related Disorders
|
December 1, 2023
Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosis
Nasim Nehzat, Richard W Browne, Diala Ghazal, et al.
Antioxidants (Basel, Switzerland)
|
January 28, 2026
Oxylipin Biomarkers of Auto-Oxidation Are Associated with Antioxidant Micronutrients and Multiple Sclerosis Disability
Taylor R Wicks, Anna Wolska, Diala Ghazal, et al.
Journal of Environmental Exposure Assessment
|
April 9, 2026
Exposure to a mixture of four metals and associations with urinary oxidative stress biomarkers in Uruguayan adolescents
Katarzyna Kordas, David L Glotzer, Gauri Desai, et al.
Oncotarget
|
October 20, 2022
Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models
Diala Ghazal, Fatma Zalzala, John C Fisk, et al.
Annals of Clinical and Translational Neurology
|
November 14, 2025
Frailty Exacerbates Disability in Progressive Multiple Sclerosis
Taylor R Wicks, Anna Wolska, Diala Ghazal, et al.
Translational Oncology
|
February 26, 2018
Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging
Loukia G Karacosta, John C Fisk, Joseph Jessee, et al.
Neoplasia (New York, N.Y.)
|
December 27, 2017
Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733]
Swetha Tati, John C Fisk, Julia Abdullah, et al.
Page
of 2